Deep Tech Startups

Galaxy Brain Scientific develops personalized brain mapping and neuromodulation technologies for research and clinical applications across neurological conditions. The company combines proprietary platform technology for individual brain functional mapping with a non-invasive stimulation system to support precision neuroscience research.

1 investor

GBI Biomanufacturing manufactures stem cells for regenerative medicine applications, including treatments for orthopedic injuries, wound care, and arthritic conditions. The company operates a 40,000-square-foot facility in Plantation, Florida and has expanded its stem-cell production capacity to serve growing demand driven by new state legislation permitting broader clinical use of stem-cell therapies.

1 investor

GCS develops advanced biomaterials through proprietary technologies including silk-fibroin fusion materials, RNA hydrogels, and ion-engineered PLLA for scalable real-world applications. The company operates at the intersection of scientific discovery and materials innovation.

1 investor

GCT develops 5G semiconductor solutions and chipsets, working with infrastructure and device manufacturers. It serves the mobile and telecommunications hardware ecosystem.

1 investor

Gearbox Biosciences develops Pop-Out-Plasmid (POP) technology, an E. coli platform that produces plasmid DNA and recombinant proteins without antibiotic selection markers or chemical inducers like IPTG, while decoupling growth from production. Its products serve biopharma partners in gene therapy, cell therapy, and vaccine manufacturing, and the technology is available for licensing.

1 investor

geCKo Materials develops an energy-efficient biomimetic adhesive for commercial and consumer applications that reduces environmental impact and simplifies attachment processes. The company manufactures and commercializes gecko-inspired adhesive technology for scaling adoption across industrial and consumer markets.

1 investor

Geegah develops a chip-based ultrasonic imaging platform that captures high-resolution video of micro- and nano-scale living samples, such as nematodes, in their natural environments without requiring light. The technology uses high-gigahertz ultrasonic waves to image tiny objects in optically opaque settings like soil, targeting researchers as an alternative to conventional microscopes.

1 investor

Gelest manufactures specialty silanes, silicones, metal-organic compounds, and acrylates for advanced technology markets including coatings, adhesives, medical devices, life sciences, and personal care. The company operates manufacturing facilities, R&D labs, and logistics centers with capabilities spanning custom synthesis, surface modification, and analytical services.

1 investor

GemaTEG develops thermal management solutions for high-performance computing systems, focusing on improving efficiency and reducing energy consumption in AI and HPC environments. The company serves cloud and computing infrastructure operators seeking to balance performance with environmental responsibility.

1 investor

GEn1E is a life sciences company developing next-generation substrate-specific p38α kinase inhibitors to treat rare and inflammatory diseases. It combines a curated database linking genes, pathways, proteins, diseases, and compounds with machine learning models spanning drug discovery through clinical trials.

1 investor

GeneLancet develops proprietary LgRNA technology for precise gene editing, with applications in CRISPR polymerase-directed therapies targeting neurodegenerative diseases and cancers with unmet medical needs.

1 investor

GeneNeer develops advanced gene-editing platforms to accelerate the development of crop seeds with improved yield, growth, and nutritional value for the agricultural supply chain. The company uses proprietary methods offering superior efficiency, precision, speed and affordability compared to existing CRISPR and similar technologies.

1 investor

Generable develops statistical and computational models for drug development and healthcare decision-making, leveraging Bayesian methods and probabilistic modeling. The company serves pharmaceutical and biotech organizations in developing safer and more efficient therapeutic interventions.

1 investor

General Aeronautics develops unmanned aerial vehicle (drone) technologies, including a spray drone platform for precision agriculture and crop protection, and offers aircraft design and UAV development services for aircraft OEMs. It applies its aeronautical, AI, and agronomy expertise to address challenges in agriculture, healthcare, and drone design.

1 investor

General Inception is an operational support and company building firm that handles day-to-day planning and execution for building companies, with a focus on life science tools and diagnostics.

1 investor

General Oceans is a group of underwater technology businesses that design, manufacture and support subsea systems including ADCP and DVL instruments, sonar imaging, underwater robotics and ocean data collection. It serves customers in defense, ocean science and marine construction operating in demanding marine environments across more than 65 countries.

1 investor

General Radar develops radar and weapons systems technology for the defense and aerospace sectors. The company serves government and military customers requiring advanced sensor and missile defense capabilities.

1 investor

General Tensor is a vertically integrated business focused on decentralized AI within the Bittensor network, operating across subnet development, validation, and mining. It builds and acquires assets—such as its RoundTable21 validator and Project Rubicon, a bridge from Bittensor to Base—to produce and support decentralized AI infrastructure.

1 investor

General Orbit develops magnetic navigation systems and sensors that enable positioning and navigation in GPS-denied or noisy environments for critical infrastructure and autonomous platforms. The company simplifies the design and deployment of these systems to increase reliability and reduce dependence on traditional GPS.

1 investor

General Robotics builds GRID, a development platform that lets organizations deploy and compose modular AI skills for perception, planning, and action across many robot types including humanoids, arms, quadrupeds, and aerial and wheeled robots. The platform supports simulation-based evaluation and rapid deployment across cloud, on-prem, and edge for robotics fleets in areas such as manufacturing and logistics.

1 investor

Generation Space is a space investment and management firm that appears to operate through Seraphim Space Manager LLP. The company manages investment vehicles and funds focused on the space sector.

1 investor

Genesis AI develops Eno, a general-purpose humanoid-capability robot with twenty degrees of freedom designed to operate across factories, laboratories, hospitals, and homes. The company builds a robotics foundation model called GENE and a simulation platform (Genesis World) that trains robots through large numbers of simulated trials.

1 investor

Genesis AI develops general-purpose humanoid robots powered by its own foundation model, aimed at performing physical tasks across factories, laboratories, hospitals, and homes. It also builds a full-stack simulation platform to accelerate robot training.

1 investor

Genesys Aerosystems, part of Moog, provides avionics systems and integration for fixed-wing and rotary aircraft, including the OASIS open-architecture display software and the Genesys Avionics Suite. It serves military and defense, business, and general aviation customers, offering avionics modernization, certification, and pilot training services.

1 investor